Hedgepath, Llc - Net Worth and Insider Trading

Hedgepath, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hedgepath, Llc owns 1 companies in total, including Inhibitor Therapeutics Inc (INTI) .

Click here to see the complete history of Hedgepath, Llc’s form 4 insider trades.

Insider Ownership Summary of Hedgepath, Llc

Ticker Comapny Transaction Date Type of Owner
INTI Inhibitor Therapeutics Inc 2014-08-14 10 percent owner

Hedgepath, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hedgepath, Llc Ownership Network

Ownership Network List of Hedgepath, Llc

No Data

Ownership Network Relation of Hedgepath, Llc

Insider Network Chart

Hedgepath, Llc Owned Company Details

What does Inhibitor Therapeutics Inc do?

Who are the key executives at Inhibitor Therapeutics Inc?

Hedgepath, Llc is the 10 percent owner of Inhibitor Therapeutics Inc. Other key executives at Inhibitor Therapeutics Inc include 10 percent owner Ronald E Osman Irrevocable Trust Iii , director & 10 percent owner Ronald E Osman , and 10 percent owner Tpb 2012 Llc .

Inhibitor Therapeutics Inc (INTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Inhibitor Therapeutics Inc (INTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inhibitor Therapeutics Inc (INTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Inhibitor Therapeutics Inc (INTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inhibitor Therapeutics Inc Insider Transactions

No Available Data

Hedgepath, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Hedgepath, Llc. You might contact Hedgepath, Llc via mailing address: 324 South Hyde Park Ave, Suite 350, Tampa Fl 33606.